At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
LCHF, Ketogenic Dietother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities and Psychiatric Symptoms in Patients With Bipolar or Schizophrenia Illness: A Pilot Trial
In Brief
A clinical study evaluating LCHF, Ketogenic Diet for Obesity and 7 related conditions. Completed, enrolled 23 participants across 1 site.
Detailed Summary
To initiate a low-carbohydrate, high-fat (LCHF) or ketogenic dietary (KD) intervention among a cohort of outpatients with either schizophrenia or bipolar illness who also have metabolic abnormalities, overweight/obesity, and/or are currently taking psychotropic medications experiencing metabolic side effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Ketogenic Dieting, Metabolic Syndrome, Bipolar Disorder, Schizophrenia, Weight Gain, Psychotropic Agents Causing Adverse Effects in Therapeutic Use, Brain Metabolic Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartFeb 2019
First PostedMay 2019
Primary CompletionAug 2022
TodayJul 2026
First PostedMay 2, 2019
Enrollment StartFeb 13, 2019
Primary CompletionAug 11, 2022
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.2 years ago
Interventions
LCHF, Ketogenic Dietother
Low Carbohydrate, Moderate Protein, High Fat Ketogenic Dietary Intervention 16 weeks